0001193125-23-064947.txt : 20230309
0001193125-23-064947.hdr.sgml : 20230309
20230308212850
ACCESSION NUMBER: 0001193125-23-064947
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230308
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 23717977
BUSINESS ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6157247755
MAIL ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foley Mark J
CENTRAL INDEX KEY: 0001529196
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: ZELTIQ AESTHETICS INC.
STREET 2: 4698 WILLOW ROAD SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
144
1
primary_doc.xml
144
0001529196
XXXXXXXX
LIVE
0001479290
Revance Therapeutics, Inc.
001-36297
1222 Demonbreun St
Suite 2000
Nashville
TN
37203
615-724-7755
Mark Foley
Officer
Common
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
75000
2475000.00
82800000
03/08/2023
NASD
Revance Common
03/07/2023
RSU Vesting
Revance Therapeutics
N
75000
03/07/2023
cash
Y
Shares sold to cover taxes from a RSU vest
03/08/2023
/s/ Dwight Moxie, Attorney-in-Fact